Related Experiment Video
Updated: May 23, 2026

08:49
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Discovery of new quinoline ether inhibitors with high affinity and selectivity for PDGFR tyrosine kinases
Patrick A Plé1, Frédéric Jung, Sue Ashton
1AstraZeneca, Centre de Recherches, BP 1050, 51689 Reims Cedex 2, France. patrick.ple@astrazeneca.com
Bioorganic & Medicinal Chemistry Letters
|April 14, 2012
Abstract:
A new series of quinoline ether inhibitors, which potently and selectively inhibit PDGFR tyrosine kinases, is described in this Letter. Compounds 23 and 33 are selective, low nanomolar inhibitors of PDGFRα and β, display good pharmacokinetics in rat and dog and are active in vivo at low doses when given orally twice daily. Further evaluation of these compounds is warranted.